Dr Lal Pathlabs

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE600L01024
  • NSEID: LALPATHLAB
  • BSEID: 539524
INR
2,874.50
-10.8 (-0.37%)
BSENSE

Dec 12

BSE+NSE Vol: 1.6 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000163,
    "name": "Dr Lal Pathlabs",
    "stock_name": "Dr Lal Pathlabs",
    "full_name": "Dr Lal Pathlabs Ltd",
    "name_url": "stocks-analysis/dr-lal-pathlabs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,874.50",
    "chg": -10.8,
    "chgp": "-0.37%",
    "dir": -1,
    "prev_price": "2,885.30",
    "mcapval": "24,336.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539524,
    "symbol": "LALPATHLAB",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE600L01024",
    "curr_date": "Dec 12",
    "curr_time": "",
    "bse_nse_vol": "1.6 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 12, 2025",
    "traded_date_str": "2025 12 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-lal-pathlabs-1000163-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dr Lal Pathlabs Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-technical-momentum-shifts-amid-bearish-signals-3755983",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DrLalPathlabs_technicaldot_3755983.png",
        "date": "2025-12-11 08:13:06",
        "description": "Dr Lal Pathlabs, a key player in the healthcare services sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent data reveals a transition from a mildly bearish trend to a sideways movement, underscoring a period of consolidation amid broader sector dynamics."
      },
      {
        "title": "Dr Lal Pathlabs Faces Mixed Signals Amidst Market and Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-lal-pathlabs-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3754862",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DrLalPathlabs_mojoScore_3754862.png",
        "date": "2025-12-10 08:19:41",
        "description": "Dr Lal Pathlabs, a prominent player in the healthcare services sector, is currently navigating a complex market environment marked by contrasting financial results and technical indicators. Recent shifts in evaluation metrics reflect a nuanced view of the company’s performance, valuation, and market sentiment."
      },
      {
        "title": "Dr Lal Pathlabs Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-faces-mildly-bearish-momentum-amid-technical-shifts-3754763",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DrLalPathlabs_technicaldot_3754763.png",
        "date": "2025-12-10 08:11:45",
        "description": "Dr Lal Pathlabs has experienced a notable shift in its technical momentum, reflecting a transition from a sideways trend to a mildly bearish stance. This change is underscored by a complex interplay of technical indicators, including the MACD, RSI, Bollinger Bands, and moving averages, which collectively paint a nuanced picture of the stock’s near-term trajectory within the healthcare services sector."
      },
      {
        "title": "Dr Lal Pathlabs Technical Momentum Shifts Amid Sideways Market Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-faces-technical-momentum-shift-amid-market-pressure-3752876",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DrLalPathlabs_technicaldot_3752876.png",
        "date": "2025-12-09 08:17:34",
        "description": "Dr Lal Pathlabs, a prominent player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent market data and technical indicators reveal a complex picture of price action and momentum, reflecting broader sectoral and market dynamics as the stock navigates a challenging environment."
      },
      {
        "title": "Why is Dr Lal Pathlabs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dr-lal-pathlabs-fallingrising-3752371",
        "imagepath": "",
        "date": "2025-12-09 00:59:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Dr Lal Pathlabs has experienced a downward trajectory over the past week, with its stock price declining by 3.73%, significantly underperforming the Sensex, which fell by only 0.63% during the same period. Over the last month, the stock has dropped 5.05%, while the Sensex gained 2.27%. Year-to-date, the stock remains down by 1.61%, contrasting with the Sensex’s robust 8.91% rise. This divergence highlights the stock’s relative weakness amid a generally positive market environment.</p>\n<p>The stock’s performance over longer horizons also indicates a lag behind the broader market. Over one year, Dr Lal Pathlabs is down 3.69%, whereas the Sensex has appreciated by 4.15%. Even over three and five years, the stock’s gains of 19.90% and 3..."
      },
      {
        "title": "Dr Lal Pathlabs Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-technical-momentum-shifts-amid-mixed-indicator-signals-3740291",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DrLalPathlabs_technicaldot_3740291.png",
        "date": "2025-12-02 08:10:30",
        "description": "Dr Lal Pathlabs has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is reflected in a variety of technical indicators, including moving averages and momentum oscillators, which present a nuanced picture of the stock’s near-term trajectory within the healthcare services sector."
      },
      {
        "title": "Dr Lal Pathlabs Technical Momentum Shifts Amid Sideways Market Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-technical-momentum-shifts-amid-sideways-trend-3737528",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DrLalPathlabs_technicaldot_3737528.png",
        "date": "2025-12-01 08:04:25",
        "description": "Dr Lal Pathlabs has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more sideways trend. This change is reflected across key technical indicators including MACD, RSI, and moving averages, signalling a period of consolidation for the healthcare services company amid broader market fluctuations."
      },
      {
        "title": "Dr Lal Pathlabs Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-lal-pathlabs-downgraded-to-hold-by-marketsmojo-amid-valuation-concerns-3730744",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrLalPathlabs_mojoScore_3730744.png",
        "date": "2025-11-26 09:46:59",
        "description": "Dr Lal Pathlabs has experienced a revision in its market evaluation, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of strong operational metrics tempered by valuation concerns and evolving market sentiment."
      },
      {
        "title": "Dr Lal Pathlabs Adjusts Quality Grade Amidst Strong Financial Metrics and Promoter Stake Changes",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-lal-pathlabs-stock-rating-downgraded-from-buy-to-hold-3669949",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrLalPathlabs_mojoScore_3669949.png",
        "date": "2025-11-04 09:01:15",
        "description": "Dr Lal Pathlabs has experienced a change in its quality grade, now rated as good. The company has shown strong financial metrics, including significant sales and EBIT growth, a solid balance sheet, and high management efficiency. However, its long-term growth outlook appears more modest, with a slight reduction in promoter stake."
      }
    ],
    "total": 262,
    "sid": "1000163",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-lal-pathlabs-1000163"
  },
  "announcements": [
    {
      "details": "Dr. Lal Path Labs Ltd. has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Dr. Lal Path Labs Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Dr. Lal Path Labs Ltd. has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Dr. Lal Path Labs Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Dr. Lal Path Labs Ltd. has informed the Exchange regarding Compliance under Regulation 23(9) : Please find enclosed Related Party Transaction for the half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "Dr. Lal Path Labs Ltd. - Other General Purpose",
      "datetime": "22-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lal Pathlabs Ltd has declared <strong>70%</strong> dividend, ex-date: 07 Nov 25",
          "dt": "2025-11-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Dr Lal Pathlabs falling/rising?

2025-12-09 00:59:27

Recent Price Movement and Market Comparison

Dr Lal Pathlabs has experienced a downward trajectory over the past week, with its stock price declining by 3.73%, significantly underperforming the Sensex, which fell by only 0.63% during the same period. Over the last month, the stock has dropped 5.05%, while the Sensex gained 2.27%. Year-to-date, the stock remains down by 1.61%, contrasting with the Sensex’s robust 8.91% rise. This divergence highlights the stock’s relative weakness amid a generally positive market environment.

The stock’s performance over longer horizons also indicates a lag behind the broader market. Over one year, Dr Lal Pathlabs is down 3.69%, whereas the Sensex has appreciated by 4.15%. Even over three and five years, the stock’s gains of 19.90% and 3...

Read More
stock-recommendationAnnouncement

Dr. Lal Path Labs Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates

09-Dec-2019 | Source : NSE

Dr. Lal Path Labs Ltd. has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Dr. Lal Path Labs Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates

28-Nov-2019 | Source : NSE

Dr. Lal Path Labs Ltd. has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Dr. Lal Path Labs Ltd. - Other General Purpose

22-Nov-2019 | Source : NSE

Dr. Lal Path Labs Ltd. has informed the Exchange regarding Compliance under Regulation 23(9) : Please find enclosed Related Party Transaction for the half year ended September 30, 2019.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Dr Lal Pathlabs Ltd has declared 70% dividend, ex-date: 07 Nov 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available